Cargando…
TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
BACKGROUND: Esophageal carcinoma is the eighth prevalent malignancy and ranks the sixth in carcinoma-related death worldwide. Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2) has been identified as a tumor suppressor in multiple carcinomas. However, its roles and molecular mechanisms underly...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773041/ https://www.ncbi.nlm.nih.gov/pubmed/29343267 http://dx.doi.org/10.1186/s12967-018-1383-0 |
_version_ | 1783293496930598912 |
---|---|
author | Zhu, Linan Zhang, Xudong Fu, Xiaorui Li, Zhaoming Sun, Zhenchang Wu, Jingjing Wang, Xinhua Wang, Feng Li, Xiangke Niu, Songtao Ding, Mengjie Yang, Zhenzhen Yang, Wanqiu Yin, Meifeng Zhang, Lei Zhang, Mingzhi |
author_facet | Zhu, Linan Zhang, Xudong Fu, Xiaorui Li, Zhaoming Sun, Zhenchang Wu, Jingjing Wang, Xinhua Wang, Feng Li, Xiangke Niu, Songtao Ding, Mengjie Yang, Zhenzhen Yang, Wanqiu Yin, Meifeng Zhang, Lei Zhang, Mingzhi |
author_sort | Zhu, Linan |
collection | PubMed |
description | BACKGROUND: Esophageal carcinoma is the eighth prevalent malignancy and ranks the sixth in carcinoma-related death worldwide. Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2) has been identified as a tumor suppressor in multiple carcinomas. However, its roles and molecular mechanisms underlying esophageal carcinoma progression are still undefined till now. METHODS: RT-qPCR assay was employed to detect the expression of TIPE2 mRNA. TIPE2 protein expression was measured by using western blot assay. Ad-V and Ad-TIPE2 adenoviruses were constructed to overexpress TIPE2. The effects of TIPE2 overexpression on cell proliferation, invasion and apoptosis were assessed by MTT and Edu incorporation assays, transwell invasion assay and flow cytometry analysis, respectively. The effect of TIPE2 overexpression on xenograft tumor growth was determined by measuring tumor volume and weight, together with immunohistochemistry assay. The effect of TIPE2 overexpression on the Wnt/β-catenin signaling pathway was evaluated by detecting the protein levels of β-catenin, c-Myc and cyclinD1 in EC9076 cells and xenograft tumors of esophageal carcinoma. RESULTS: TIPE2 expression was downregulated in esophageal carcinoma tissues and cells. Adenovirus-mediated TIPE2 overexpression suppressed cell proliferation and invasion, and induced apoptosis in esophageal carcinoma cells. Enforced expression of TIPE2 inhibited tumor growth in vivo, as evidenced by the reduced tumor volume, tumor weight and proliferating cell nuclear antigen expression. Overexpression of TIPE2 inhibited the Wnt/β-catenin signaling pathway in esophageal carcinoma in vitro and in vivo. CONCLUSIONS: These results suggest that TIPE2 suppressed progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway. |
format | Online Article Text |
id | pubmed-5773041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57730412018-01-26 TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway Zhu, Linan Zhang, Xudong Fu, Xiaorui Li, Zhaoming Sun, Zhenchang Wu, Jingjing Wang, Xinhua Wang, Feng Li, Xiangke Niu, Songtao Ding, Mengjie Yang, Zhenzhen Yang, Wanqiu Yin, Meifeng Zhang, Lei Zhang, Mingzhi J Transl Med Research BACKGROUND: Esophageal carcinoma is the eighth prevalent malignancy and ranks the sixth in carcinoma-related death worldwide. Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2) has been identified as a tumor suppressor in multiple carcinomas. However, its roles and molecular mechanisms underlying esophageal carcinoma progression are still undefined till now. METHODS: RT-qPCR assay was employed to detect the expression of TIPE2 mRNA. TIPE2 protein expression was measured by using western blot assay. Ad-V and Ad-TIPE2 adenoviruses were constructed to overexpress TIPE2. The effects of TIPE2 overexpression on cell proliferation, invasion and apoptosis were assessed by MTT and Edu incorporation assays, transwell invasion assay and flow cytometry analysis, respectively. The effect of TIPE2 overexpression on xenograft tumor growth was determined by measuring tumor volume and weight, together with immunohistochemistry assay. The effect of TIPE2 overexpression on the Wnt/β-catenin signaling pathway was evaluated by detecting the protein levels of β-catenin, c-Myc and cyclinD1 in EC9076 cells and xenograft tumors of esophageal carcinoma. RESULTS: TIPE2 expression was downregulated in esophageal carcinoma tissues and cells. Adenovirus-mediated TIPE2 overexpression suppressed cell proliferation and invasion, and induced apoptosis in esophageal carcinoma cells. Enforced expression of TIPE2 inhibited tumor growth in vivo, as evidenced by the reduced tumor volume, tumor weight and proliferating cell nuclear antigen expression. Overexpression of TIPE2 inhibited the Wnt/β-catenin signaling pathway in esophageal carcinoma in vitro and in vivo. CONCLUSIONS: These results suggest that TIPE2 suppressed progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway. BioMed Central 2018-01-17 /pmc/articles/PMC5773041/ /pubmed/29343267 http://dx.doi.org/10.1186/s12967-018-1383-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhu, Linan Zhang, Xudong Fu, Xiaorui Li, Zhaoming Sun, Zhenchang Wu, Jingjing Wang, Xinhua Wang, Feng Li, Xiangke Niu, Songtao Ding, Mengjie Yang, Zhenzhen Yang, Wanqiu Yin, Meifeng Zhang, Lei Zhang, Mingzhi TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway |
title | TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway |
title_full | TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway |
title_fullStr | TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway |
title_full_unstemmed | TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway |
title_short | TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway |
title_sort | tipe2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the wnt/β-catenin pathway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773041/ https://www.ncbi.nlm.nih.gov/pubmed/29343267 http://dx.doi.org/10.1186/s12967-018-1383-0 |
work_keys_str_mv | AT zhulinan tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT zhangxudong tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT fuxiaorui tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT lizhaoming tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT sunzhenchang tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT wujingjing tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT wangxinhua tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT wangfeng tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT lixiangke tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT niusongtao tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT dingmengjie tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT yangzhenzhen tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT yangwanqiu tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT yinmeifeng tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT zhanglei tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway AT zhangmingzhi tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway |